Squalene epoxidase (Erg1p) is an essential enzyme in the ergosterol biosynthesis pathway in yeast. For its enzymatic activity, Erg1p requires molecular oxygen, NAD(P)H and FAD. Amino acid analysis and sequence alignment with other squalene epoxidases revealed two highly conserved FAD-binding domains, FAD I and FAD II. By random PCR mutagenesis of the ERG1 gene, one erg1 allele was isolated that carries a mutation leading to a single amino acid exchange in the FAD I domain close to the N-terminus of Erg1p. This erg1 allele codes for functional squalene epoxidase and renders yeast cells hypersensitive to terbinafine. Amino acid exchanges of other conserved residues in the FAD I and FAD II regions either led to non-functional squalene epoxidase or to the formation of squalene epoxidase with wild-type properties. These results describe the importance of specific amino acids for enzymatic activity in the yeast squalene epoxidase Erg1p.
Introduction
Sterols are essential components of all eukaryotic cells and responsible for a number of membrane characteristics. The main sterol in fungal membranes is ergosterol that exhibits a great variety of functions that modulate membrane fluidity, permeability, and the activities of membrane-bound enzymes [1] . In addition, ergosterol provides the so-called 'sparking' function that is associated with cell-cycle regulation [2, 3] . Since ergosterol is an essential membrane component its complex biosynthesis pathway provides a large number of potential targets for antifungal drugs; and indeed, some of the most effective compounds in the treatment of systemic and superficial fungal infections, like azoles and allylamines, are inhibitors of essential enzymes of the pathway. Azoles inhibit lanosterol-14α-demethylase, encoded by the ERG11 gene [4] , and the ERG1 gene product squalene epoxidase is the target for allylamines, such as naftifine and terbinafine [5] . Other essential enzymatic steps of ergosterol biosynthesis have not yet been evaluated as targets for novel antifungal drugs [6] . The yeast Saccharomyces cerevisiae has been successfully used as a model system to elucidate the enzymology of ergosterol biosynthesis and the regulation of ergosterol levels. The coordinated function of 28 proteins is required for ergosterol synthesis (for recent reviews see [1, 7] ). All genes coding for these proteins in yeast have been cloned and identified Key words: allylamine, ergosterol synthesis, FAD-binding site, squalene epoxidase, terbinafine sensitivity, yeast. Abbreviation used: PHBH, p-hydroxybenzoate hydroxylase. 1 To whom correspondence should be addressed (email friederike.turnowsky@uni-graz.at).
with ERG27 [8] and ERG28 [9] being the most recent additions.
Squalene epoxidases
One of the essential steps committed to the synthesis of sterols in fungi and higher eukaryotes is performed by squalene epoxidases (for a recent review, see [10] ). These enzymes are mono-oxygenases that catalyse the insertion of an oxygen atom into the linear squalene molecule to form 2,3-oxidosqualene ( Figure 1 ). Fungal and mammalian squalene epoxidases share some important features: (i) all of them are microsomal enzymes, (ii) the enzymatic activity depends on the presence of molecular oxygen and a reducing cofactor, NADPH or NADH, and (iii) they are stimulated by FAD [11] . The affinities of the enzymes of different origins for the substrate squalene are also comparable. However, there are also significant differences between mammalian and fungal squalene epoxidases: mammalian squalene epoxidase activity is stimulated by a cytosolic protein, termed supernatant protein factor (SPF) [12] , fungal enzymes are sensitive to a variety of detergents [11, 13, 14] , and mammalian and fungal enzymes are selectively sensitive to various squalene epoxidase inhibitors, such as allylamines, which is of medical importance.
In recent years, the number of cloned genes encoding squalene epoxidases has increased significantly, including those of fungi, plants and mammals. In addition, new GenBank R entries of uncharacterized or putative squalene epoxidases are available. Their relative distances are displayed in a phylogenetic tree in Figure 2 . Squalene epoxidases of mammals and plants cluster nicely with respect to their kingdom, whereas fungal squalene epoxidases are much more divergent and, overall, only very distantly related to their mammalian counterparts. This fact may reflect the selective sensitivities to various allylamines of either mammalian or fungal squalene epoxidases.
Squalene epoxidase of S. cerevisiae (Erg1 protein)
Like squalene epoxidases of other origins, yeast squalene epoxidase, Erg1p, requires molecular oxygen and the reducing cofactor NADPH for enzyme activity and is stimulated by FAD [15] . Erg1 protein exhibits low specific activity in comparison with enzymes that are involved in early steps of sterol synthesis, strongly suggesting that squalene epoxidase catalyses a rate-limiting step and is, therefore, of importance in regulating the amount of sterols synthesized by yeast [16] . The gene encoding squalene epoxidase, ERG1, was first isolated and characterized from the genomic library of the terbinafine-resistant S. cerevisiae mutant A2M8 [17] . It codes for the 55 kDa Erg1 protein, consisting of 496 amino acids, which is essential for yeast growing in the presence of oxygen [18] . However, yeast mutants that contain an interrupted ERG1 gene, and thus lack squalene epoxidase activity, are viable when grown anaerobically. In the absence of oxygen, [32] . h, hydrophobic residues; s, small residues; x, all residues.
yeast can supplement the lack of ergosterol by taking up sterols from the medium [19] . This phenotype provides a selection procedure to screen for complementation of the aerobically lethal phenotype by expression of functional squalene epoxidase. Allylamines, such as naftifine and terbinafine, inhibit ergosterol biosynthesis in fungi at the point of squalene epoxidation [14, 20] . Treated cells accumulate squalene and are depleted of ergosterol, which finally leads to growth inhibition. As demonstrated in cell-free extracts of Candida albicans, inhibition of squalene epoxidase by allylamines is reversible and displays non-competitive kinetics with respect to the substrate squalene, NADH and FAD [21] . Since structural data for squalene epoxidases are not yet available, the interaction between fungal squalene epoxidase and the inhibitor, i.e. terbinafine, including the amino acid(s) that bind terbinafine, has not been elucidated. Random chemical and UV mutagenesis of S. cerevisiae strains led to the isolation of terbinafine-resistant mutants [22, 23] . The ERG1 genes of these mutants carry single base-pair exchanges causing single amino acid substitutions in the Erg1 protein. Each of the mutations was sufficient to confer resistance to terbinafine and they are clustered in two regions of the Erg1 protein: the central part of the protein and the C-terminal portion (Figure 3A) , which is a strong indication that these regions are crucial and specific for Erg1p-terbinafine interactions.
Terbinafine exerts high selectivity for fungal squalene epoxidases; inhibition of mammalian squalene epoxidases requires three orders of magnitude higher terbinafine concentrations [13, 24] . On the other hand, the allylamine derivative NB598 is a specific inhibitor of mammalian squalene epoxidase and 1000-fold higher concentrations of NB598 are needed to inhibit fungal squalene epoxidases [13, 25] . Both terbinafine and NB598, regardless of their selectivity, inhibit fungal squalene epoxidases in a non-competitive manner with regard to squalene and inhibit mammalian squalene epoxidase competitively [24] . Structure-activity relationship data of numerous allylamine derivatives has led to the model of an allylamine-binding site consisting of two separate binding sites, one for the aromatic ring and the other for the lipophilic side chain. The location of such binding sites might be different in mammalian and fungal squalene epoxidases [24] . The significant difference in the relationship between mammalian and fungal squalene epoxidases (Figure 2 ) and the existence of kingdom-specific domains may be the cause of the selectivity of certain allylamines. In addition, the divergence within fungal squalene epoxidases (Figure 2) may also reflect the different degree of inhibitory activity of terbinafine for different fungal species.
In the terbinafine-resistant squalene epoxidases that have been described, all amino acid exchanges except one involve residues that are conserved in all squalene epoxidases [22, 23] , indicating that not so much single amino acids, but highly conserved regions in the fungal squalene epoxidases (kingdom-specific domains) are responsible for the selectivity of terbinafine inhibition. Similar results are reported for azole resistance in C. albicans caused by mutations in the Erg11 protein [26] [27] [28] .
FAD 'fingerprints' in S. cerevisiae squalene epoxidase
Due to the lack of structural data, the enzyme PHBH ( p-hydroxybenzoate hydroxylase) of Pseudomonas sp. serves as a prototype for FAD-dependent hydroxylases [29] and it is the only enzyme in this class of flavoproteins for which a three-dimensional structure is available [30] . PHBH shares only 20% sequence identity with rat liver squalene epoxidase and 18% with the enzyme from S. cerevisiae, but several highly conserved sequence motifs are present in all enzymes ( Figure 3B ). The FAD 'fingerprint' in the N-terminal portion of these proteins represents a typical βαβ-fold containing the GXGXXG sequence that binds the ADP moiety of FAD [31] . This domain is now referred to as the FAD I 'fingerprint' since a novel sequence motif, Gly-Asp, was identified that appears to be important for the binding of both FAD and NAD(P)H and was designated FAD II [32] .
Both FAD 'fingerprints' are present in the yeast squalene epoxidase ( Figure 3B, boldface letters) . In order to learn more about the domains in the Erg1 protein that are involved in the enzyme activity and drug interaction, the ERG1 gene of S. cerevisiae was randomly mutagenized in vitro by PCR, and erg1 alleles expressing modified squalene epoxidase were isolated by functional complementation of the aerobically lethal phenotype of a squalene epoxidase deficient S. cerevisiae mutant [18] , as well as terbinafine sensitivity. Sequence analysis of one erg1 allele conferring terbinafine sensitivity revealed a single mutation that caused a Gly 30 -Ser modification in the FAD I 'fingerprint' of the Erg1 protein. The sitespecific amino acid exchange Gly 27 -Ser in the FAD I 'fingerprint' did not alter the functionality of squalene epoxidase or the sensitivity to terbinafine, whereas the Gly 25 -Ser exchange leads to loss of complementation and enzymatic activity of Erg1p ( Figure 3A ) (C. Ruckenstuhl, A. Eidenberger, S. Lang and F. Turnowsky, unpublished work). These results indicate the importance of specific amino acids in the FAD I site for enzyme activity.
Recently, photoaffinity labelling and site-directed mutagenesis of recombinant squalene epoxidase derived from rat liver led to the identification of amino acids that are involved in substrate binding, FAD interaction, catalytic activity and protein stability [33, 34] . Competitive squalene epoxidase inhibitors were used to label the substrate-binding site. A short peptide of 24 amino acids, corresponding to amino acid residues 388-411 of full-length rat squalene epoxidase, was labelled by the substrate analogue. These results provide the first evidence for the localization of the substrate-binding site in mammalian squalene epoxidase. The proposed substratebinding site is, however, not a region of high homology between mammalian and fungal squalene epoxidases, but one amino acid comprises part of the FAD II motif Gly 334 -Asp
335
( Figure 3B , boldface letters). By site-specific mutagenesis, the amino acid Gly 334 in S. cerevisiae squalene epoxidase was substituted with alanine without loss of functionality as measured by complementation of the aerobically lethal phenotype of a squalene epoxidase-deficient yeast mutant [18] and the strain carrying the mutated allele was more sensitive to terbinafine compared with wild-type. The exchange of Asp 335 to Ala did not alter functionality or terbinafine sensitivity; however, when the aspartic residue was replaced by amino acids with bulky groups, such as phenylalanine or tryptophan or by proline the enzyme, although expressed, is not functional and can, thus, not complement squalene epoxidase deficiency ( Figure 3A ) (C. Ruckenstuhl, A. Eidenberger, S. Lang and F. Turnowsky, unpublished work).
Outlook
The identification of two FAD 'fingerprints' in squalene epoxidases on the basis of sequence similarities to PHBH of Pseudomonas sp. provides a valuable tool to elucidate the importance of specific amino acids for structure and activity of squalene epoxidases and the interaction between the specific inhibitors and the respective target protein. Site-specific exchanges of various amino acids will help to characterize further the critical domains of squalene epoxidases, and together with resolving the structure will deepen our knowledge of this enzyme and provide possibilities to design improved antifungal compounds.
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